TNF inhibitor
In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include:
SELECT-CHOICE study. ABA vs. UPA in…
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
Long Delays in Denosumab Increase Fracture Risk (SAT0453). A UK population based study looked at risk of fracture in…
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
Voclosporin Effective in Lupus Nephritis (OP0277). Voclosporin is a calcineurin inhibitor that has performed well in an…
Updated EULAR Recommendations for RA Management
Dr. Kathryn Dao from EULAR2020 Virtual Conference
Imaging and Remission Axial Spondyloarthritis
Dr. Olga Petryna from EULAR2020 Virtual Conference
OP0079 - what MRI findings are most predictive in AxSpa
OP0314 - Drug free remission in AxSpA
Biosimilars in Spondyloarthritis
Dr. Rachel Tate from EULAR2020 Virtual Conference 0632
- ETN Biosimilar in Reactive Arthritis 0650
- Treasure Study in infliximab biosimilar in SpA
4 years 11 months ago
Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis?
@Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats)
Something to consider in these difficult-to-treat pts?
@LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU
4 years 11 months ago
Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before or during pregnancy. Few on TNFi were continued on tx during pregnancy. #EULAR2020 @RheumNow https://t.co/t7B6pASeWQ https://t.co/BwU6RF5Qkn
Poster Hall